Anagrelide

Back to search

Molecule Structure

Scientific Name

Anagrelide

Description of the Drug

Anagrelide is a platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00261

Brand Name(s)

Not Available

Company Owner(s)

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Takeda Pharmaceuticals Usa Inc, Watson Laboratories, Chartwell Rx Sciences Llc, Roxane Laboratories Inc, Mylan Pharmaceuticals Inc, Barr Laboratories Inc, Impax Laboratories Inc, Torrent Pharmaceuticals Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Phosphodiesterase 3 PROTEIN FAMILY INHIBITOR CHEMBL2094125

Unichem Links

SureChEMBL SCHEMBL9411
PharmGKB PA164742986
Human Metabolome Database HMDB0014406
DrugBank DB00261
PubChem: Thomson Pharma 14798804 14774505
PubChem 135409400
LINCS LSM-3380
Nikkaji J18.596E
PDBe J33
BindingDB 50000334
DrugCentral 209
ChemicalBook CB8246866
Guide to Pharmacology 7114
rxnorm AGRYLIN ANAGRELIDE HYDROCHLORIDE ANAGRELIDE
ChEBI 142290
ZINC ZINC000003871541